Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC

NCT06844487 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

344

Enrollment

OTHER

Sponsor class

Conditions

Mpox (Monkeypox)
Vaccination
Immunogenicity
Safety
Infants
Children

Interventions

BIOLOGICAL: MVA-BN standard regimen
BIOLOGICAL: MVA-BN half-dose regimen

Sponsor

Jean-Pierre Van geertruyden

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]